Inside a $175M Deal: Tim McLoughlin & Joshua Hayes Live From RDU Startup Week
What's Shaping the Capital Raising Environment?
Raising a Down Round and How to Be Prepared
Developing an AI Policy for Your Startup
Due Diligence in AI: Thinking like your biggest critic
JONES DAY TALKS®: A Trip to the Dark Side – Venture Capital Down Rounds and Recaps
PODCAST: Williams Mullen's Raising Capital 101: A Securities Podcast - Why Raise Capital?
PODCAST: Williams Mullen's Raising Capital 101: A Securities Podcast - The Aspects of Raising Capital from Start-Ups to More Established Companies
Embracing Change & Community: The Keys To Startup Success With Chris Heivly
The Best of Founder Shares: Highlights Wisdom of Season's Guests
A Conversation with Janade du Plessis of Launch Africa Ventures: Balancing Sustainable Development with ROI
The Force is Strong with this One – Success and Paying it Forward with Co-Founder of ChannelAdvisor and Spiffy Scot Wingo
Hunting Outsized Returns with Jason Caplain of Bull City Venture Partners
Through the Lens: From serial entrepreneur to neutral who gets deals done - Focus on Daniel Garrie
A View From the Starting Line – A Conversation with Teenpreneur Tierney Schmidt
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 159: Bob Quinn, Executive Director, and Adrianne Grimes, Director of Marketing and Comms, SCRA
From Accidental Entrepreneur to a $2.5M raise, with Cycle Labs' Josh Owen
The One Reason Startups Fail, with VentureSouth's Charlie Banks
When Two is Better Than One: Murphy’s Naturals and The Loading Dock Story with Philip Freeman
Huddling with Hutch adVENTURES: Behind the scenes with an early-stage venture capital firm
From lab to commercialization: Navigate the evolving risks of life science companies - Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding...more
As global markets continue to adapt to a new normal, a clear understanding of the structural nuances, risk considerations, and strategic objectives inherent in varying transaction structures enables investors to remain agile...more
As often as we hear of the success stories of entrepreneurs, we are not always as privy to the many behind-the-scenes challenges they face. We may hear even less about the legal framework guiding their entrepreneurial dreams....more
As more public — and even private — companies will need to address ESG expectations, some simple strategies can help companies chart a course from the beginning. As the global focus on environmental, social, and...more
“Down rounds” and why they are contentious - Early-stage companies often raise capital in multiple rounds. While founders and investors hope that a company’s valuation is on a one-way trip upwards, the next round could be...more
Welche rechtlichen Stolpersteine solltest du beim Gründen und Wachsen beachten? Bei unserem Online-Seminar „Legal FAQs: Die wichtigsten Fragen & Antworten“ stehen dir unsere Experten Rede und Antwort. Auch 2020 ist McDermott...more
What legal stumbling blocks should you be aware of when founding and growing? Our experts are available to answer your questions at our online seminar “Legal FAQs: The most important questions and answers”. In 2020,...more
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the...more
Some interesting links we found across the web this week: Wristbands, velvet ropes, and more: 5 SXSW hacks for startups - Thousands of startups have descended on Austin for today’s opening of SXSW 2016....more